Health choices predict cancer survival, U-M study findsApril 02, 2009Pretreatment alcohol, tobacco, fruit, exercise habits linked to head and neck cancer survival ANN ARBOR, Mich. - Head and neck cancer patients who smoked, drank, didn't exercise or didn't eat enough fruit when they were diagnosed had worse survival outcomes than those with better health habits, according to a new study from the University of Michigan Comprehensive Cancer Center. "While there has been a recent emphasis on biomarkers and genes that might be linked to cancer survival, the health habits a person has at diagnosis play a major role in his or her survival," says study author Sonia Duffy, Ph.D., R.N., associate professor of nursing at the U-M School of Nursing, research assistant professor of otolaryngology at the U-M Medical School, and research scientist at the VA Ann Arbor Healthcare System. Each of the factors was independently associated with survival. Results of the study appear online in the Journal of Clinical Oncology. The researchers surveyed 504 head and neck cancer patients about five health behaviors: smoking, alcohol use, diet, exercise and sleep. Patients were surveyed every three months for two years then yearly after that. Smoking was the biggest predictor of survival, with current smokers having the shortest survival. Problem drinking and low fruit intake were also associated with worse survival, although vegetable intake was not. Lack of exercise also appears to decrease survival. "Health behaviors are only sporadically addressed in busy oncology clinics where the major focus is on surgery, chemotherapy or radiation. Addressing health behaviors may enhance the survival advantage offered by these treatments," says Duffy, a U-M Cancer Center investigator. Complicating matters is that many of these health behaviors are inter-related. For example, smokers might also be heavy drinkers, making it more difficult to quit. It's not enough, Duffy points out, to refer someone to a smoking cessation program if alcohol is a major underlying problem. In addition, previous research has associated many of these health behaviors with preventing cancer. In the current study, a third of the patients reported eating fewer than four servings of fruit per month. Nutrition experts recommend two servings of fruit per day. "Eating fruits and vegetables, not smoking and drinking in moderation can have a big impact on a person's risk of getting cancer in the first place. Now it appears that these factors also impact survival after diagnosis," Duffy says. The next step for the researchers is to look at behavior changes over time to determine if changing health habits when a person is diagnosed can impact survival. That will help determine what types of interventions or services should be offered to patients in the clinic. University of Michigan Health System |
|||||||||||||||||||||
| Related Cancer Survival Current Events and Cancer Survival News Articles African-Americans with colorectal cancer have poorer outcomes, lower survival rates New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans. Small peptide found to stop lung cancer tumor growth in mice In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world. Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor. Cost-effective strategy to screen second primary colorectal cancers in cancer survivors To suggest a feasible economic strategy for second primary colorectal cancer screening of cancer survivors in Korea, A research group constructed a decision-analytic model, compared cost-effectiveness results of cancer screening in male cancer survivors. Genetic factors implicated in survival gap for breast, ovarian or prostate cancer A new finding reveals that African-American patients with breast, ovarian, and prostate cancer tend to die earlier than patients of other races with these cancers, even when they receive identical medical treatment and when socioeconomic factors are controlled for. 2 reproductive factors are important predictors of death from ovarian cancer Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles. Researchers identify biological markers that may indicate poor breast cancer prognosis A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation. Exercise programs may improve symptoms in non-small cell lung cancer patients Exercise is known to have a positive effect on maintaining a healthy lifestyle, and a study in the May issue of the Journal of Thoracic Oncology has shown that exercise also plays an important role in both primary and secondary prevention of cancer. Study of neighborhoods points to modifiable factors, not race, in cancer disparities While cities have shown considerable racial disparities in cancer survival, those racial disparities virtually disappear among smaller populations, such as neighborhoods within that city. New drug shows promise in treating drug-resistant prostate cancer A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. More Cancer Survival Current Events and Cancer Survival News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||